Maestro Antonio, Pipa Iván, Rodríguez Nicolás, Toyos Carmen, Torrontegui-Duarte Marcelino, Castaño Cesar
Hospital Begoña, Avda, Pablo Iglesias 92, 33204 Gijón, Spain.
Real Sporting Gijon SAD, Camino Mareo-Granda, 645, 33390 Gijon, Spain.
Medicina (Kaunas). 2021 Mar 19;57(3):287. doi: 10.3390/medicina57030287.
Injuries to the knee ligaments can be particularly disabling in young patients, given the risk of long-term disability if adequate fixation is not achieved during initial repair. The TWINFIX™ titanium (Ti) suture anchor with ULTRABRAID™ Suture (Smith and Nephew, London, UK) was designed to secure tendon and ligament reconstructions with increased boney ingrowth at the anchor site with minimal invasive technique. This retrospective analysis looked at 33 patients (41 implants) operated with this device between 2015 and 2019 at a single institution. The average age of patients was 33.18 years (standard deviation [SD], 15.26), with an average body mass index of 24.88 (SD, 3.49). The indications were lateral extra-articular tenodesis during anterior cruciate ligament reconstruction, medial patellofemoral ligament reconstruction, quadriceps or patellar tendon repair and medial collateral ligament repair. After an average follow up of 24.3 + 6.53 months, there was no reports of clinical failure or radiographic evidence of implant failure or loosening. One patient experienced a complication unrelated to the study device, requiring manipulation under anesthesia with resolution of symptoms. This case series supports the safety and performance of this implants for the knee procedures in which its use is indicated. Additional follow-up will be required to determine whether these effects are sustained at medium- and long-term durations.
膝关节韧带损伤对于年轻患者可能具有特别严重的致残性,因为如果在初次修复时未实现充分固定,则存在长期残疾的风险。采用ULTRABRAID™缝线的TWINFIX™钛(Ti)缝线锚钉(英国伦敦的施乐辉公司)旨在通过微创技术确保肌腱和韧带重建,并增加锚钉部位的骨长入。这项回顾性分析研究了2015年至2019年期间在单一机构使用该装置进行手术的33例患者(41枚植入物)。患者的平均年龄为33.18岁(标准差[SD],15.26),平均体重指数为24.88(SD,3.49)。适应症包括前交叉韧带重建术中的外侧关节外腱固定术、内侧髌股韧带重建术、股四头肌或髌腱修复术以及内侧副韧带修复术。平均随访24.3 + 6.53个月后,没有临床失败的报告,也没有植入物失败或松动的影像学证据。一名患者出现了与研究装置无关的并发症,需要在麻醉下进行手法治疗,症状得以缓解。该病例系列支持了这种植入物在其适用的膝关节手术中的安全性和性能。需要进一步随访以确定这些效果在中长期是否持续存在。